查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
体外膜肺氧合 (ECMO) 市场预测到 2028 年 - COVID-19 影响和按模式、应用和年龄组的全球分析
市场调查报告书
商品编码
1171984

体外膜肺氧合 (ECMO) 市场预测到 2028 年 - COVID-19 影响和按模式、应用和年龄组的全球分析

Extracorporeal Membrane Oxygenation Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Modality, Application, and Age Group
出版日期: | 出版商: The Insight Partners | 英文 162 Pages | 订单完成后即时交付

价格

体外膜肺氧合 (ECMO) 预计将从 2021 年的 5.4673 亿美元增至 2028 年的 6.7764 亿美元，预计 2022 年至 2028 年的复合年增长率为 3.1%

报告重点介绍了推动市场发展的关键因素以及公司的主要发展。 体外膜肺氧合器市场的增长主要是由于心血管疾病和呼吸衰竭的患病率上升以及肺移植手术中越来越多地采用体外膜氧合器。 然而，与体外膜氧合相关的并发症阻碍了市场增长。

心血管疾病和呼吸衰竭患病率上升推动体外膜氧合器市场增长

体外膜肺氧合是一种体外循环装置。 体外膜肺氧合器用于治疗心血管疾病和呼吸衰竭。 心血管疾病 (CVD) 每年在全世界夺去数百万人的生命。 CVD 是欧洲死亡和发病的主要原因，占欧洲地区死亡人数的 45% 和欧盟 (EU) 死亡人数的 37%。 根据《2019 年全球疾病负担研究》的研究，CVD 是 2019 年亚洲地区的主要死因之一，导致 1080 万人死亡（占所有死亡人数的 35%）。 2022 年心脏病和中风统计数据更新情况说明书“全球疾病负担”显示，2020 年全球估计有 1.191 亿患者死于 CVD。 它还指出，2020 年全球中风和缺血性中风的患病率分别为 8910 万和 6820 万。 北美是 CVD 发病率最高的地区。 根据国家慢性病预防和健康促进中心心脏病和中风预防部的数据，心脏病在美国造成 697,000 人死亡。 据美国心臟协会称，到 2035 年，美国将有超过 1.3 亿人（占总人口的 45.1%）可能患有某种形式的心血管疾病。 根据国家医学图书馆的数据，到 2022 年，每年将进行约 40 万例冠状动脉旁路移植术 (CABG)。

慢性阻塞性肺病 (COPD) 是一种肺部气流受阻，导致呼吸衰竭的疾病。 它是威胁生命的疾病之一，在全世界造成数百万人死亡。 根据世界卫生组织 (WHO) 的数据，慢性阻塞性肺病是第三大死因，2019 年全球造成 323 万人死亡。 大约 90% 的 COPD 死亡发生在低收入和中等收入国家。 根据 CDC（疾病控制与预防中心）的数据，COPD 是 2020 年美国第六大死因。 因此，心血管疾病和呼吸衰竭患病率的上升正在推动体外膜氧合市场的增长。

体外膜肺氧合器的全球市场根据形态分为静脉-动脉体外膜肺氧合器、静脉内体外膜肺氧合器和动静脉体外膜肺氧合器。增加。 静脉动脉体外膜肺氧合治疗部分将在 2021 年占据最大的市场份额，预计在预测期内的市场复合年增长率为 3.1%。 静脉-动脉 (VA) 体外膜氧合通过将血液推过绕过患者心臟的迴路来支持患者的心臟和肺部。 这种类型的体外膜氧合从大静脉抽取血液并将其返回到大动脉，即使在心臟泵血能力受损的情况下，也能使富含氧气的血液在全身循环。 静脉-动脉体外膜氧合（VA-extracorporeal membrane oxygenation）在过去十年中得到广泛应用。 这是治疗各种病因难治性心源性休克的有效且有价值的治疗方法。 它在院内心臟骤停的独特环境中显示出可喜的结果，据报导存活率为 20-40%，并具有良好的神经学结果。

体外膜肺氧合器的全球市场根据应用分为呼吸系统和心臟系统。 由于体外膜肺氧合用于肺衰竭恢復期患者，呼吸领域将在 2021 年占据很大的市场份额。 急性呼吸窘迫综合征 (ARDS)、肺部肺动脉闭塞（肺栓塞）和 COVID-19 是一些使用体外膜肺氧合治疗的肺部疾病，会降低肺功能。它可以在没有任何支持的情况下支持患者的身体 体外膜氧合也用于支持患有无法治癒的心脏病的人，同时等待器官移植。 用于治疗心脏病发作（急性心肌梗塞）、心肌病（代偿性心肌病）和心力衰竭。 根据世界卫生组织的数据，2019 年心血管疾病导致 1790 万人死亡，占全球所有死亡人数的 32%。 心血管疾病患病率的增加可能会在未来几年增加对体外膜肺氧合器的需求。

食品和药物管理局、统计和规划与执行部、国家统计和区域研究所、国家药品监督管理局是准备体外膜氧合市场报告时参考的主要和次要信息来源是

内容

第一章介绍

  • 调查范围
  • Insight Partners 研究报告指南
  • 市场细分
    • 按模式划分的全球体外膜氧合市场
    • 全球体外膜肺氧合器市场：按应用分类
    • 全球体外膜肺氧合市场：按年龄组分类
    • 全球体外膜氧合器市场 - 按地区

第二章重点

第三章研究方法论

  • 范围
  • 二次调查
  • 初步调查

第4章体外膜肺氧合器市场：市场状况

  • 害虫分析
    • 北美 PEST 分析
    • 欧洲 PEST 分析
    • 亚太地区 PEST 分析
    • 中东和非洲 PEST 分析
    • 拉丁美洲 PEST 分析
  • 专家意见

第 5 章体外膜氧合器市场：主要市场动态

  • 市场驱动力
    • 心血管疾病和呼吸衰竭的患病率上升
    • 扩大体外膜肺氧合器在肺移植手术中的应用
  • 市场製约因素
    • 与体外膜氧合相关的并发症
  • 市场机会
    • 通过体外膜氧合器提高存活率
  • 未来趋势
    • 产品开发和批准激增
  • 影响分析

第 6 章全球体外膜氧合器市场-分析

  • 全球体外膜氧合器市场：收入预测和分析
    • 全球体外膜氧合器市场：收入预测和分析
  • 体外膜氧合器市场主要参与者的市场定位分析

第 7 章体外膜氧合器市场：到 2028 年的分析和预测（按模式）

  • 全球体外膜肺氧合器市场：2021 年和 2028 年按模式划分的份额 (%)
  • 静脉-动脉：体外膜肺氧合器
  • 静脉：体外膜肺氧合器
  • 动静脉：体外膜肺氧合器

第 8 章体外膜肺氧合器市场：到 2028 年的分析和预测（按应用）

  • 全球体外膜肺氧合器市场：按应用分类，2021 年和 2028 年 (%)
  • 心脏病学
  • 呼吸科

第 9 章体外膜氧合器市场：到 2028 年的分析和预测（按年龄组）

  • 全球体外膜肺氧合市场：按年龄组划分，2021 年和 2028 年 (%)
  • 新生儿
  • 儿科
  • 成人

第 10 章全球体外膜氧合器市场：收入和到 2028 年的预测，区域分析

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳大利亚
    • 其他亚太地区
  • 中美洲和南美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 中东和非洲
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • 其他中东地区

第 11 章 COVID-19 大流行对体外膜氧合器市场的影响

  • 北美
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第十二章体外膜肺氧合器市场：行业现状

  • 体外膜氧合器市场增长战略
  • 无机增长战略
  • 有机增长战略

第13章公司简介

  • Terumo Group
  • Medtronic Plc
  • MicroPort Scientific Corporation
  • LivaNova Plc
  • Nipro Medical Corporation
  • Eurosets S.R.L.
  • Getinge AB
  • Braile Biomedica
  • Fresenius Medical Care AG & Co KGaA
  • ABIOMED Inc

第14章附录

  • 关于 Insight Partners
  • 词彙表
Product Code: TIPHE100001219

The extracorporeal membrane oxygenation market is projected to reach US$ 677.64 million by 2028 from US$ 546.73 million in 2021; it is estimated to grow at a CAGR of 3.1% during 2022-2028.

The report highlights the key factors driving the market and prominent players with their developments. The growth of the extracorporeal membrane oxygenation market is primarily attributed to the rising prevalence of cardiovascular diseases and respiratory failures and the growing adoption of extracorporeal membrane oxygenation in lung transplantation procedures. However, complications associated with extracorporeal membrane oxygenation hinder the growth of the market.

Rising Prevalence of Cardiovascular Diseases and Respiratory Failures Drives extracorporeal membrane oxygenation Market Growth

Extracorporeal membrane oxygenation (extracorporeal membrane oxygenation) is a heart-lungs bypass machine. extracorporeal membrane oxygenation equipment is used in the treatment of cardiovascular diseases and respiratory failures. Millions of deaths due to cardiovascular diseases (CVDs) are recorded every year across the world. CVDs majorly cause mortality and morbidity in Europe, accounting for 45% of deaths in the region and 37% in the European Union (EU). As per the study 'Global Burden of Disease Study 2019,' CVDs were among the leading causes of death in Asia in 2019, causing 10.8 million fatalities (35% of the total fatalities). According to the 2022 Heart Disease & Stroke Statistical Update Fact Sheet, Global Burden of Disease, an estimated 119.1 million patients died of CVDs across the world in 2020. It also stated that the global prevalence of stroke and ischemic stroke in 2020 was 89.1 million and 68.2 million, respectively. High instances of CVDs are observed in North America. As per the National Center for Chronic Disease Prevention and Health Promotion, Division for Heart Disease and Stroke Prevention, ~697,000 people succumbed to heart disease in the US. According to the American Heart Association, over 130 million people in the US (45.1% of total population) are likely to get affected by some form of cardiovascular disease by 2035. Further, according to the National Library of Medicine, in 2022, about 400,000 coronary artery bypass grafting (CABG) surgeries are performed every year.

Chronic obstructive pulmonary disease (COPD) causes obstruction in the airflow from the lungs, which can lead to respiratory failure. It is one of the life-threatening illnesses that cause millions of deaths across the world. According to World Health Organization (WHO), COPD was the third leading cause of death, which caused 3.23 million deaths across the globe in 2019. About 90% of COPD deaths occur in low- and middle-income countries. According to the Centers for Disease Control and Prevention (CDC), in 2020, COPD was the sixth leading cause of death in the US. Therefore, the growing prevalence of cardiovascular diseases and respiratory failures drives the growth of the extracorporeal membrane oxygenation market.

The global extracorporeal membrane oxygenation market, based on modality, is segmented into venoarterial extracorporeal membrane oxygenation, venovenous extracorporeal membrane oxygenation, and arteriovenous extracorporeal membrane oxygenation. The venoarterial extracorporeal membrane oxygenation segment held the largest share of the market in 2021 and is anticipated to register a CAGR of 3.1% in the market during the forecast period. Venoarterial (VA) extracorporeal membrane oxygenation supports the patient's heart and lungs by pushing the blood through the circuit without getting through the patient's heart. This type of extracorporeal membrane oxygenation takes blood out of a large vein and back it into a large artery, allowing oxygen-rich blood to circulate through the body even if the heart is too weak to pump. Veno-arterial extracorporeal membrane oxygenation (VA-extracorporeal membrane oxygenation) has been widely applied over the last decade. It is an effective and valuable therapeutic option in refractory cardiogenic shock of various etiologies. It showed promising results in the specific setting of in-hospital cardiac arrest, and survival rates with good neurological outcomes are reported between 20% and 40%.

Based on application, the global extracorporeal membrane oxygenation market is bifurcated into respiratory and cardiology. The respiratory segment held a larger share of the market in 2021 as extracorporeal membrane oxygenation is used for patients recovering from lung failure. Acute respiratory distress syndrome (ARDS), Blockage in a pulmonary artery in the lungs (pulmonary embolism), and COVID-19 are a few lung diseases where extracorporeal membrane oxygenation is used. extracorporeal membrane oxygenation can support patients body in total absence of lung function. However, the cardiology segment is anticipated to register a CAGR of 3. 6% in the market during the forecast period. extracorporeal membrane oxygenation is also used to support people affected by heart disease that cannot be cured while they wait for an organ transplant. It is used in the treatment of heart attack (acute myocardial infarction), heart muscle disease (decompensated cardiomyopathy), and heart failure. As per the WHO, in 2019, due to CVDs ~17.9 million deaths were recorded accounting for 32% of all global deaths. Increasing prevalence of cardiovascular diseases is likely to increase the demand for extracorporeal membrane oxygenation machines in the coming years.

Food and Drug Administration, Ministry of Statistics and Program Implementation, National Institute of Statistics and Geography, and National Medical Products Administration are a few of the major primary and secondary sources referred to while preparing the report on the extracorporeal membrane oxygenation market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the extracorporeal membrane oxygenation market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global extracorporeal membrane oxygenation market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Extracorporeal Membrane Oxygenation Market - By Modality
    • 1.3.2 Global Extracorporeal Membrane Oxygenation Market - By Application
    • 1.3.3 Global Extracorporeal Membrane Oxygenation Market - By Age Group
    • 1.3.4 Global Extracorporeal Membrane Oxygenation Market - By Geography

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Extracorporeal Membrane Oxygenation Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East & Africa PEST Analysis
    • 4.2.5 South & Central America PEST Analysis
  • 4.3 Experts Opinion

5. Extracorporeal Membrane Oxygenation Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Prevalence of Cardiovascular Diseases and Respiratory Failures
    • 5.1.2 Growing Adoption of Extracorporeal Membrane Oxygenation in Lung Transplantation Procedures
  • 5.2 Market Restraints
    • 5.2.1 Complications Associated with Extracorporeal Membrane Oxygenation
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Survival Rates with Extracorporeal Membrane Oxygenation
  • 5.4 Future Trends
    • 5.4.1 Surging Product Developments and Approvals
  • 5.5 Impact Analysis

6. Extracorporeal Membrane Oxygenation Market - Global Analysis

  • 6.1 Global Extracorporeal Membrane Oxygenation Market Revenue Forecast & Analysis
    • 6.1.1 Global Extracorporeal Membrane Oxygenation Market Revenue Forecast & Analysis
  • 6.2 Market Positioning Analysis of Key Players in Extracorporeal Membrane Oxygenation Market

7. Extracorporeal Membrane Oxygenation Market Analysis and Forecast To 2028 - By Modality

  • 7.1 Overview
  • 7.2 Global Extracorporeal Membrane Oxygenation Market Share by Modality 2021 & 2028 (%)
  • 7.3 Venoarterial Extracorporeal Membrane Oxygenation
    • 7.3.1 Overview
    • 7.3.2 Venoarterial Extracorporeal Membrane Oxygenation: Extracorporeal Membrane Oxygenation Market Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Venovenous Extracorporeal Membrane Oxygenation
    • 7.4.1 Overview
    • 7.4.2 Venovenous Extracorporeal Membrane Oxygenation: Extracorporeal Membrane Oxygenation Market Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Arteriovenous Extracorporeal Membrane Oxygenation
    • 7.5.1 Overview
    • 7.5.2 Arteriovenous Extracorporeal Membrane Oxygenation: Extracorporeal Membrane Oxygenation Market Revenue and Forecast to 2028 (US$ Million)

8. Extracorporeal Membrane Oxygenation Market Analysis and Forecasts To 2028 - By Application

  • 8.1 Overview
  • 8.2 Global Extracorporeal Membrane Oxygenation Market, By Application 2021 & 2028 (%)
  • 8.3 Cardiology
    • 8.3.1 Overview
    • 8.3.2 Cardiology Market Revenue and Forecast to 2028 (US$ Mn)
  • 8.4 Respiratory
    • 8.4.1 Overview
    • 8.4.2 Respiratory Market Revenue and Forecast to 2028 (US$ Mn)

9. Extracorporeal Membrane Oxygenation Market Analysis and Forecasts To 2028 - By Age Group

  • 9.1 Overview
  • 9.2 Global Extracorporeal Membrane Oxygenation Market, By Age Group 2021 & 2028 (%)
  • 9.3 Neonates
    • 9.3.1 Overview
    • 9.3.2 Neonates Market Revenue and Forecast to 2028 (US$ Mn)
  • 9.4 Pediatrics
    • 9.4.1 Overview
    • 9.4.2 Pediatrics Market Revenue and Forecast to 2028 (US$ Mn)
  • 9.5 Adults
    • 9.5.1 Overview
    • 9.5.2 Adults Market Revenue and Forecast to 2028 (US$ Mn)

10. Extracorporeal Membrane Oxygenation Market Revenue and Forecasts to 2028 - Geographical Analysis

  • 10.1 North America: Extracorporeal Membrane Oxygenation Market
    • 10.1.1 Overview
    • 10.1.2 North America: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.1.3 North America: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
    • 10.1.4 North America: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
    • 10.1.5 North America: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
    • 10.1.6 North America: Extracorporeal Membrane Oxygenation Market, by Country, 2021 & 2028 (%)
      • 10.1.6.1 US: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.1.1 Overview
        • 10.1.6.1.2 US: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.1.3 US: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
        • 10.1.6.1.4 US: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
        • 10.1.6.1.5 US: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
      • 10.1.6.2 Canada: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.2.1 Overview
        • 10.1.6.2.2 Canada: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.2.3 Canada: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
        • 10.1.6.2.4 Canada: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
        • 10.1.6.2.5 Canada: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
      • 10.1.6.3 Mexico: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.3.1 Overview
        • 10.1.6.3.2 Mexico: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.3.3 Mexico: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
        • 10.1.6.3.4 Mexico: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
        • 10.1.6.3.5 Mexico: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
  • 10.2 Europe: Extracorporeal Membrane Oxygenation Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.3 Europe: Extracorporeal Membrane Oxygenation Market, By Modality, 2019-2028 (US$ Million)
    • 10.2.4 Europe: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
    • 10.2.5 Europe: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
    • 10.2.6 Europe: Extracorporeal Membrane Oxygenation Market, by Country, 2021 & 2028 (%)
      • 10.2.6.1 Germany: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.1 Overview
        • 10.2.6.1.2 Germany: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.3 Germany: Extracorporeal Membrane Oxygenation Market, By Modality, 2019-2028 (US$ Million)
        • 10.2.6.1.4 Germany: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
        • 10.2.6.1.5 Germany: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
      • 10.2.6.2 UK: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.1 Overview
        • 10.2.6.2.2 UK: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.3 UK: Extracorporeal Membrane Oxygenation Market, By Modality, 2019-2028 (US$ Million)
        • 10.2.6.2.4 UK: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
        • 10.2.6.2.5 UK: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
      • 10.2.6.3 France: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.1 Overview
        • 10.2.6.3.2 France: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.3 France: Extracorporeal Membrane Oxygenation Market, By Modality, 2019-2028 (US$ Million)
        • 10.2.6.3.4 France: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
        • 10.2.6.3.5 France: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
      • 10.2.6.4 Italy: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.1 Overview
        • 10.2.6.4.2 Italy: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.3 Italy: Extracorporeal Membrane Oxygenation Market, By Modality, 2019-2028 (US$ Million)
        • 10.2.6.4.4 Italy: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
        • 10.2.6.4.5 Italy: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
      • 10.2.6.5 Spain: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.1 Overview
        • 10.2.6.5.2 Spain: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.3 Spain: Extracorporeal Membrane Oxygenation Market, By Modality, 2019-2028 (US$ Million)
        • 10.2.6.5.4 Spain: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
        • 10.2.6.5.5 Spain: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
      • 10.2.6.6 Rest of Europe: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.1 Overview
        • 10.2.6.6.2 Rest of Europe: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.3 Rest of Europe: Extracorporeal Membrane Oxygenation Market, By Modality, 2019-2028 (US$ Million)
        • 10.2.6.6.4 Rest of Europe: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
        • 10.2.6.6.5 Rest of Europe: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
  • 10.3 Asia Pacific: Extracorporeal Membrane Oxygenation Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.3.3 Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
    • 10.3.4 Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
    • 10.3.5 Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
    • 10.3.6 Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Country, 2021 & 2028 (%)
      • 10.3.6.1 China: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.1.1 Overview
        • 10.3.6.1.2 China: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.1.3 China: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.1.4 China: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
        • 10.3.6.1.5 China: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
      • 10.3.6.2 Japan: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.2.1 Overview
        • 10.3.6.2.2 Japan: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.2.3 Japan: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.2.4 Japan: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
        • 10.3.6.2.5 Japan: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
      • 10.3.6.3 India: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.3.1 Overview
        • 10.3.6.3.2 India: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.3.3 India: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.3.4 India: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
        • 10.3.6.3.5 India: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
      • 10.3.6.4 South Korea: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.4.1 Overview
        • 10.3.6.4.2 South Korea: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.4.3 South Korea: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.4.4 South Korea: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
        • 10.3.6.4.5 South Korea: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
      • 10.3.6.5 Australia: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.5.1 Overview
        • 10.3.6.5.2 Australia: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.5.3 Australia: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.5.4 Australia: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
        • 10.3.6.5.5 Australia: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
      • 10.3.6.6 Rest of Asia Pacific: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.1 Overview
        • 10.3.6.6.2 Rest of Asia Pacific: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.3 Rest of Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
        • 10.3.6.6.5 Rest of Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
  • 10.4 South & Central America Extracorporeal Membrane Oxygenation Market
    • 10.4.1 Overview
    • 10.4.2 South & Central America: Extracorporeal Membrane Oxygenation - Revenue and Forecast to 2028 (US$ Million)
    • 10.4.3 South & Central America: Extracorporeal Membrane Oxygenation, by Modality, 2019-2028 (US$ Million)
    • 10.4.4 South & Central America: Extracorporeal Membrane Oxygenation, by Application, 2019-2028 (US$ Million)
    • 10.4.5 South & Central America: Extracorporeal Membrane Oxygenation, by Age Group, 2019-2028 (US$ Million)
    • 10.4.6 South & Central America: Extracorporeal Membrane Oxygenation, by Country, 2021 & 2028 (%)
      • 10.4.6.1 Brazil: Extracorporeal Membrane Oxygenation - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.1.1 Brazil: Extracorporeal Membrane Oxygenation - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.1.2 Brazil: Extracorporeal Membrane Oxygenation, by Modality, 2019-2028 (US$ Million)
        • 10.4.6.1.3 Brazil: Extracorporeal Membrane Oxygenation, by Application, 2019-2028 (US$ Million)
        • 10.4.6.1.4 Brazil: Extracorporeal Membrane Oxygenation, by Age Group, 2019-2028 (US$ Million)
      • 10.4.6.2 Argentina: Extracorporeal Membrane Oxygenation - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.2.1 Argentina: Extracorporeal Membrane Oxygenation - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.2.2 Argentina: Extracorporeal Membrane Oxygenation, by Modality, 2019-2028 (US$ Million)
        • 10.4.6.2.3 Argentina: Extracorporeal Membrane Oxygenation, by Application, 2019-2028 (US$ Million)
        • 10.4.6.2.4 Argentina: Extracorporeal Membrane Oxygenation, by Age Group, 2019-2028 (US$ Million)
      • 10.4.6.3 Rest of South & Central America: Extracorporeal Membrane Oxygenation - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.3.1 Rest of South & Central America: Extracorporeal Membrane Oxygenation - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.3.2 Rest of South & Central America: Extracorporeal Membrane Oxygenation, by Modality, 2019-2028 (US$ Million)
        • 10.4.6.3.3 Rest of South & Central America: Extracorporeal Membrane Oxygenation, by Application, 2019-2028 (US$ Million)
        • 10.4.6.3.4 Rest of South & Central America: Extracorporeal Membrane Oxygenation, by Age Group, 2019-2028 (US$ Million)
  • 10.5 Middle East & Africa: Extracorporeal Membrane Oxygenation Market
    • 10.5.1 Middle East & Africa: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
    • 10.5.2 Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Modality, 2019-2028 (US$ Million)
    • 10.5.3 Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
    • 10.5.4 Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
    • 10.5.5 Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Country, 2021& 2028 (%)
      • 10.5.5.1 South Africa: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.5.5.1.1 Overview
        • 10.5.5.1.2 South Africa: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.5.5.1.3 South Africa: Extracorporeal Membrane Oxygenation Market, by Modality, 2019-2028 (US$ Million)
        • 10.5.5.1.4 South Africa: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
        • 10.5.5.1.5 South Africa: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
      • 10.5.5.2 Saudi Arabia: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.5.5.2.1 Overview
        • 10.5.5.2.2 Saudi Arabia: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.5.5.2.3 Saudi Arabia: Extracorporeal Membrane Oxygenation Market, by Modality, 2019-2028 (US$ Million)
        • 10.5.5.2.4 Saudi Arabia: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
        • 10.5.5.2.5 Saudi Arabia: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
      • 10.5.5.3 UAE: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.5.5.3.1 Overview
        • 10.5.5.3.2 UAE: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.5.5.3.3 UAE: Extracorporeal Membrane Oxygenation Market, by Modality, 2019-2028 (US$ Million)
        • 10.5.5.3.4 UAE: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
        • 10.5.5.3.5 UAE: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
      • 10.5.5.4 Rest of Middle East & Africa: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.5.5.4.1 Overview
        • 10.5.5.4.2 Rest of Middle East & Africa: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.5.5.4.3 Rest of Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Modality, 2019-2028 (US$ Million)
        • 10.5.5.4.4 Rest of Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
        • 10.5.5.4.5 Rest of Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Extracorporeal Membrane Oxygenation Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 South & Central America: Impact Assessment of COVID-19 Pandemic
  • 11.5 Middle East & Africa: Impact Assessment of COVID-19 Pandemic

12. Extracorporeal Membrane Oxygenation Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Extracorporeal Membrane Oxygenation Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Terumo Group
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Medtronic Plc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 MicroPort Scientific Corporation
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 LivaNova Plc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Nipro Medical Corporation
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Eurosets S.R.L.
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Getinge AB
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Braile Biomedica
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Fresenius Medical Care AG & Co KGaA
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 ABIOMED Inc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. North America Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. North America Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. North America Extracorporeal Membrane Oxygenation Market, by Age Group - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. US Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. US Extracorporeal Membrane Oxygenation Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 6. US Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Canada Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Canada Extracorporeal Membrane Oxygenation Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Canada Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Mexico Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Mexico Extracorporeal Membrane Oxygenation Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Mexico Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Europe: Extracorporeal Membrane Oxygenation Market, By Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Europe: Extracorporeal Membrane Oxygenation Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Europe Extracorporeal Membrane Oxygenation Market, by Age Group - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Germany: Extracorporeal Membrane Oxygenation Market, By Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Germany: Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Germany: Extracorporeal Membrane Oxygenation Market, by Age Group - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. UK: Extracorporeal Membrane Oxygenation Market, By Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. UK: Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. UK: Extracorporeal Membrane Oxygenation Market, by Age Group - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. France: Extracorporeal Membrane Oxygenation Market, By Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. France: Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. France: Extracorporeal Membrane Oxygenation Market, by Age Group - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Italy: Extracorporeal Membrane Oxygenation Market, By Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Italy: Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Italy: Extracorporeal Membrane Oxygenation Market, by Age Group - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Spain: Extracorporeal Membrane Oxygenation Market, By Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 29. Spain: Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 30. Spain: Extracorporeal Membrane Oxygenation Market, by Age Group - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. Rest of Europe: Extracorporeal Membrane Oxygenation Market, By Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 32. Rest of Europe: Extracorporeal Membrane Oxygenation Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 33. Rest of Europe: Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 34. Asia Pacific Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 35. Asia Pacific Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 36. Asia Pacific Extracorporeal Membrane Oxygenation Market, by Age Group - Revenue and Forecast to 2028 (US$ Million)
  • Table 37. China Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 38. China Extracorporeal Membrane Oxygenation Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 39. China Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 40. Japan Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 41. Japan Extracorporeal Membrane Oxygenation Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 42. Japan Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 43. India Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 44. India Extracorporeal Membrane Oxygenation Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 45. India Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 46. South Korea Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 47. South Korea Extracorporeal Membrane Oxygenation Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 48. South Korea Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 49. Australia Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 50. Australia Extracorporeal Membrane Oxygenation Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 51. Australia Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 52. Rest of Asia Pacific Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 53. Rest of Asia Pacific Extracorporeal Membrane Oxygenation Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 54. Rest of Asia Pacific Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 55. South & Central America Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 56. South & Central America Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 57. South & Central America Extracorporeal Membrane Oxygenation Market, by Age Group - Revenue and Forecast to 2028 (USD Million)
  • Table 58. Brazil Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (USD Million)
  • Table 59. Brazil Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 60. Brazil Extracorporeal Membrane Oxygenation Market, by Age Group - Revenue and Forecast to 2028 (USD Million)
  • Table 61. Argentina Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (USD Million)
  • Table 62. Argentina Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 63. Argentina Extracorporeal Membrane Oxygenation Market, by Age Group - Revenue and Forecast to 2028 (USD Million)
  • Table 64. Rest of South & Central America Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (USD Million)
  • Table 65. Rest of South & Central America Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 66. Rest of South & Central America Extracorporeal Membrane Oxygenation Market, by Age Group - Revenue and Forecast to 2028 (USD Million)
  • Table 67. Middle East & Africa Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 68. Middle East & Africa Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 69. Middle East & Africa Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 70. South Africa Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 71. South Africa Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 72. South Africa Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 73. Saudi Arabia Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 74. Saudi Arabia Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 75. Saudi Arabia Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 76. UAE Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 77. UAE Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 78. UAE Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 79. Rest of Middle East & Africa Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 80. Rest of Middle East & Africa Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 81. Rest of Middle East & Africa Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 82. Recent Inorganic Growth Strategies in the Extracorporeal Membrane Oxygenation Market
  • Table 83. Recent Organic Growth Strategies in the Extracorporeal Membrane Oxygenation Market
  • Table 84. Glossary of Terms

List Of Figures

  • Figure 1. Extracorporeal Membrane Oxygenation Market Segmentation
  • Figure 2. Extracorporeal Membrane Oxygenation Market, By Region
  • Figure 3. Global Extracorporeal Membrane Oxygenation Market Overview
  • Figure 4. Venoarterial Extracorporeal Membrane Oxygenation Held Largest Share for Modality Segment in Extracorporeal Membrane Oxygenation Market
  • Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Extracorporeal Membrane Oxygenation Market, by Geography (US$ Million)
  • Figure 7. Global Extracorporeal Membrane Oxygenation Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Extracorporeal Membrane Oxygenation Market, Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. Middle East & Africa: PEST Analysis
  • Figure 13. South & Central America: PEST Analysis
  • Figure 14. Experts Opinion
  • Figure 15. Impact Analysis
  • Figure 16. Global Extracorporeal Membrane Oxygenation Market - Revenue Forecast and Analysis - 2020- 2028
  • Figure 17. Global Extracorporeal Membrane Oxygenation Market - Revenue Forecast & Analysis - 2021 - 2028
  • Figure 18. Market Positioning Analysis of Key Players in Global Extracorporeal Membrane Oxygenation Market
  • Figure 19. Global Extracorporeal Membrane Oxygenation Market Share by Modality 2021 & 2028 (%)
  • Figure 20. Venoarterial Extracorporeal Membrane Oxygenation: Extracorporeal Membrane Oxygenation Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 21. Venovenous Extracorporeal Membrane Oxygenation: Extracorporeal Membrane Oxygenation Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 22. Arteriovenous Extracorporeal Membrane Oxygenation: Extracorporeal Membrane Oxygenation Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 23. Global Extracorporeal Membrane Oxygenation Market, by Application 2021 & 2028 (%)
  • Figure 24. Cardiology Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 25. Respiratory Market Revenue and Forecasts To 2028 (US$ MN)
  • Figure 26. Global Extracorporeal Membrane Oxygenation Market, by Age Group 2021 & 2028 (%)
  • Figure 27. Neonates Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 28. Pediatrics Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 29. Adults Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 30. North America: Extracorporeal Membrane Oxygenation Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 31. North America Extracorporeal Membrane Oxygenation Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. North America: Extracorporeal Membrane Oxygenation Market, by Country, 2021 & 2028 (%)
  • Figure 33. US: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. Canada: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Mexico: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. Europe: Extracorporeal Membrane Oxygenation Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 37. Europe Extracorporeal Membrane Oxygenation Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. Europe: Extracorporeal Membrane Oxygenation Market, by Country, 2021 & 2028 (%)
  • Figure 39. Germany: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 40. UK: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. France: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 42. Italy: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 43. Spain: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. Rest of Europe: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 45. Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 46. Asia Pacific Extracorporeal Membrane Oxygenation Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 47. Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Country, 2021 & 2028 (%)
  • Figure 48. China: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 49. Japan: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 50. India: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 51. South Korea: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 52. Australia: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 53. Rest of Asia Pacific: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 54. South & Central America: Extracorporeal Membrane Oxygenation Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 55. South & Central America Extracorporeal Membrane Oxygenation Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 56. South & Central America: Extracorporeal Membrane Oxygenation, by Country, 2021 & 2028 (%)
  • Figure 57. Brazil: Extracorporeal Membrane Oxygenation - Revenue and Forecast to 2028 (US$ Million)
  • Figure 58. Argentina: Extracorporeal Membrane Oxygenation - Revenue and Forecast to 2028 (US$ Million)
  • Figure 59. Rest of South & Central America: Extracorporeal Membrane Oxygenation - Revenue and Forecast to 2028 (US$ Million)
  • Figure 60. Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 61. Middle East & Africa Extracorporeal Membrane Oxygenation Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 62. Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Country, 2021& 2028 (%)
  • Figure 63. South Africa: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 64. Saudi Arabia: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 65. UAE: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 66. Rest of Middle East & Africa: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 67. Impact of COVID-19 Pandemic on North American Countries Markets
  • Figure 68. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 69. Impact of COVID-19 Pandemic on Asia Pacific Country Markets
  • Figure 70. Impact of COVID-19 Pandemic in South & Central America Country Markets
  • Figure 71. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
  • Figure 72. Growth Strategies in the Extracorporeal Membrane Oxygenation Market